INFLUENCE OF CYP2B6*6 GENOTYPE ON BUPROPION ENANTIOMERS METABOLISM AND CLEARANCE

被引：0
|
作者：
Kharasch, E. D. [1 ]
Crafford, A. [1 ]
Parchomski, J. [1 ]
Blood, J. [1 ]
Regina, K. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] METHADONE ENANTIOMERS METABOLISM AND CLEARANCE ARE IMPAIRED IN INDIVIDUALS WITH CYP2B6*6 GENOTYPE
    Kharasch, E. D.
    Parchomski, J.
    Regina, K.
    Blood, J.
    Yang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S53 - S54
  • [2] The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans
    Ilic, Katarina
    Hawke, Roy L.
    Thirumaran, Ranjit K.
    Schuetz, Erin G.
    Hull, J. Heyward
    Kashuba, Angela D. M.
    Stewart, Paul W.
    Lindley, Celeste M.
    Chen, Mei-Ling
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (03) : 575 - 581
  • [3] The influence of sex, race/ethnicity and CYP2B6 genotype on bupropion (B) metabolism.
    Dic, K.
    Hogeland, G.
    Rezk, N.
    White, N.
    Lamba, J.
    Lee, C.
    Kashuba, A. D.
    Schuetz, E. G.
    Lindley, C. M.
    Chen, M. L.
    Hawke, R. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S81 - S81
  • [4] The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans (vol 41, pg 575, 2013)
    IIic, K.
    Hawke, R. L.
    Thirumaran, R. K.
    Schuetz, E. G.
    Hull, J. H.
    Kashuba, A. D.
    Stewart, P. W.
    Lindley, C. M.
    Chen, M. L.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) : 1137 - 1137
  • [5] Novel CYP2B6 polymorphisms and their impact on efavirenz and bupropion metabolism
    Klein, K.
    Radloff, R.
    Gras, A.
    Masquelier, C.
    Arumugam, K.
    Karasi, J-C
    Seguin-Devaux, C.
    Zanger, U. M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S41 - S41
  • [6] Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition
    Kharasch, Evan D.
    Crafford, Amanda
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 142 - 152
  • [7] ROLE OF CYP2B6 POLYMORPHISM IN THE METABOLISM AND PHARMACOKINETICS OF METHADONE ENANTIOMERS
    Somogyi, A. A.
    Coller, J. K.
    Foster, D. B. F.
    Li, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 32 - 32
  • [8] CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial
    Lee, Anna M.
    Jepson, Christopher
    Hoffmann, Ewa
    Epstein, Leonard
    Hawk, Larry W.
    Lerman, Caryn
    Tyndale, Rachel F.
    BIOLOGICAL PSYCHIATRY, 2007, 62 (06) : 635 - 641
  • [9] Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism
    Crane, Alice L.
    Klein, Kathrin
    Zanger, Ulrich M.
    Olson, James R.
    TOXICOLOGY, 2012, 293 (1-3) : 115 - 122
  • [10] Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers
    Gufford, Brandon T.
    Metzger, Ingrid F.
    Bamfo, Nadia O.
    Benson, Eric A.
    Masters, Andrea R.
    Lu, Jessica Bo Li
    Desta, Zeruesenay
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 382 (03): : 313 - 326
12345